India, June 12 -- Emerson announced the latest additions to its NI PXI Vector Signal Transceiver (VST) portfolio designed to expand access to high-performance RF test technologies in cost-sensitive applications, including medical device development and electronic validation and production environments.

Emerson will showcase the new NI PXI Core VST instruments at the 2026 IEEE International MTT Symposia in Boston, USA.

The new Core VST instruments-including the PXIe-5841 and PXIe-5820-deliver calibrated, synchronized RF measurements in a modular platform optimized for speed, automation and ease of use. By combining high-performance RF capability with a more accessible price point, the enhanced NI VST portfolio now enables more engineerin...